Phase II Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma

Clinical trial NCT01579318 · TERMINATED

Trial details

NCT number: NCT01579318
Sponsor: OncoSec Medical Incorporated
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous T Cell Lymphomas (CTCL)Mycosis Fungoides (MF)

Start date: 2012-06-08
Primary completion: 2014-06-03
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.